Base: $193,898 to $290,847 annually; bonus/equity:...
4+ years pharmaceutical hcp marketing experience
U.s. in-line marketing execution track record
Proven experience leading product launches
This role involves shaping and executing the U.S. integrated strategy for EGFR-mutated lung cancer across the treatment paradigm
Job Summary
This role involves shaping and executing the U.S. integrated strategy for EGFR-mutated lung cancer across the treatment paradigm.
The position offers the opportunity to redefine the treatment paradigm for patients with EGFR-mutated lung cancer within an industry-leading Oncology portfolio.
AstraZeneca fosters a culture of dedication, accountability, innovation, and shared ownership while requiring a minimum of three days per week in the office.
Matching Summary
This role involves shaping and executing the U.S. integrated strategy for EGFR-mutated lung cancer across the treatment paradigm.
Salary
Base: $193,898 to $290,847 annually; Bonus/Equity: Eligible for short-term incentive bonuses and equity-based awards; Benefits: Qualified retirement programs, paid time off, health, dental, and vision coverage
Skills & Requirements
Must-have
4+ years pharmaceutical HCP marketing experience
U.S. in-line marketing execution track record
Proven experience leading product launches
Nice-to-have
Prior lung cancer or EGFR therapeutic area experience
People leadership and talent development skills
Deep knowledge of U.S. Oncology market dynamics
Key Requirements
Bachelor's degree in relevant field
4+ years pharmaceutical in-line HCP marketing experience
Demonstrated success delivering against defined KPIs